Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07215689 · ClinicalTrials.gov registry record · NA
Effects of KSM-66 Ashwagandha® (300 mg) on Skin and Hair Health in Healthy Men and Women"
A NA study of Skin Health and Hair Health, sponsored by SF Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07215689: Recruiting NA study of Skin Health and Hair Health, sponsored by SF Research Institute.
NCT07215689 is a NA study of Skin Health and Hair Health that is actively recruiting participants, run by SF Research Institute. The registered enrollment target is 50 participants, roughly in line with the 48-participant average among 4 other Skin Health trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07215689, a NA study of Skin Health and Hair Health, is actively recruiting participants, sponsored by SF Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Hair and skin play major roles in protecting the body, and maintaining their health is essential. Poor hair and skin health have become increasingly common due to the stress associated with modern lifestyles. Effective and time-efficient treatments for hair and skin health remain limited. Although hair loss, baldness, and skin issues are not life-threatening, managing these conditions is important because of the psychological and social complications-such as anxiety and depression-they can cause. There is an unmet need for therapies that provide safe and long-term improvements in hair and skin health. Many individuals seek Complementary and Alternative Medicine (CAM) to identify natural and effective options for these conditions. Adaptogens such as Ashwagandha (Withania somnifera) have long been studied for their potential to reduce stress and modulate cortisol levels in the body. Reducing stress may help prevent inflammation, a common contributor to hair shedding and loss. Ashwagandha also contains antioxidants and amino acids that may strengthen the hair and minimize breakage. Traditionally, Ashwagandha has been recognized for its multiple health benefits, including support for hair and skin wellness. However, there remains limited scientific evidence to substantiate these traditional claims, underscoring the need for controlled clinical evaluation.
Primary Outcome
Mean change in TEWL from Visit 1, Screening Visit/ Enrolment Visit/ Baseline Visit, (Day 1) to Visit 3, End of study (Week 12)
Conditions Studied
Interventions
- OTHER Placebo Capsule(s)
- DIETARY_SUPPLEMENT KSM-66 Ashwagandha® capsule
Study Locations (1)
California
- San Francisco Research Institute - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-07-11 |
| Est. Completion | 2025-12-10 |
| Phase | NA |
What NCT07215689 shows while recruiting
NCT07215689 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, roughly in line with the 48-participant average among 4 other Skin Health trials with a reported enrollment target.
The record links to 2 conditions, with Skin Health appearing as the primary indexed condition, and to 2 interventions - of which Placebo Capsule(s) is the first listed.
NCT07215689 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07215689 about?
NCT07215689 is a clinical study titled "Effects of KSM-66 Ashwagandha® (300 mg) on Skin and Hair Health in Healthy Men and Women"". Hair and skin play major roles in protecting the body, and maintaining their health is essential. Poor hair and skin health have become increasingly common due to the stress associated with modern lifestyles. Effective and time-efficient treatments for hair and skin health remain limited. Although h...
What is the current status of trial NCT07215689?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-07-11. Estimated completion is 2025-12-10.
What conditions does trial NCT07215689 study?
This clinical trial studies the following conditions: Skin Health, Hair Health.
What interventions are being tested in trial NCT07215689?
The interventions under investigation include: Placebo Capsule(s) (OTHER), KSM-66 Ashwagandha® capsule (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07215689?
This trial is sponsored by SF Research Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07215689 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Health
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Clinical Trial to Evaluate the Effects of a Skin Balm on the Appearance of the Eye Area
COMPLETED · NA
-
A Trial to Examine the Efficacy of a Hand Serum and Glove Combination.
COMPLETED · NA
-
A Single-Group Clinical Trial to Evaluate the Effects of Health Nag's BioActive Collagen Jelly on Skin, Hair, Nail, and Joint Health
COMPLETED · NA
-
Efficacy of Solarplast for Health and Oxidative Stress
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI